Skip to main content
close menu
close menu

Search UK HealthCare

Rachel L. Stewart, DO, PhD

Why are there no ratings?
Dr. Rachel Stewart
  • About

    Faculty Rank

    Assistant Professor of Pathology and Laboratory Medicine

    Degree

    Touro University College of Osteopathic Medicine, Vallejo, Calif.

    Residency

    Anatomic and Clinical Pathology, University of Kentucky

    Fellowship

    Molecular Genetic Pathology, University of Utah, ARUP Laboratories, School of Medicine, Salt Lake City

    Certifications and Special Training

    American Board of Pathology, Anatomic and Clinical Pathology

    American Board of Pathology, Molecular Genetic Pathology

  • Publications

    Publications

    1. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays. Chapel DB, Stewart R, Furtado LV, Husain AN, Krausz T, Deftereos G. Hum Pathol. 2019 Feb 19;. doi: 10.1016/j.humpath.2019.02.001. [Epub ahead of print] PubMed PMID: 30794891.
    2. Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists. Bui MM, Riben MW, Allison KH, Chlipala E, Colasacco C, Kahn AG, Lacchetti C, Madabhushi A, Pantanowitz L, Salama ME, Stewart RL, Thomas NE, Tomaszewski JE, Hammond ME. Arch Pathol Lab Med. 2019 Jan 15;. doi: 10.5858/arpa.2018-0378-CP. [Epub ahead of print] PubMed PMID: 30645156.
    3. Potential protein markers for breast cancer recurrence: a retrospective cohort study. He C, Plattner R, Rangnekar V, Zhou B, Liu C, Stewart RL, Huang B, Wang C, Tucker TC. Cancer Causes Control. 2019 Jan;30(1):41-51. doi: 10.1007/s10552-018-1099-8. Epub 2018 Nov 28. PubMed PMID: 30488343; NIHMSID:NIHMS1515270.
    4. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer. Liu J, Duan Z, Guo W, Zeng L, Wu Y, Chen Y, Tai F, Wang Y, Lin Y, Zhang Q, He Y, Deng J, Stewart RL, Wang C, Lin PC, Ghaffari S, Evers BM, Liu S, Zhou MM, Zhou BP, Shi J. Nat Commun. 2018 Dec 5;9(1):5200. doi: 10.1038/s41467-018-07258-y. PubMed PMID: 30518851; PubMed Central PMCID: PMC6281582.
    5. Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance. Xiong G, Stewart RL, Chen J, Gao T, Scott TL, Samayoa LM, O'Connor K, Lane AN, Xu R. Nat Commun. 2018 Oct 26;9(1):4456. doi: 10.1038/s41467-018-06893-9. PubMed PMID: 30367042; PubMed Central PMCID: PMC6203834.